Product Program year 2021 Source: CMS Open Payments

Advantage

Device Stress Urinary Incontinence

PDI 08714729470274

Open in the dashboard

General payments

$9,658

67 payments

Research payments

$0

0 payments

Through program year 2021, $9,658 in general payments and $0 in research payments were reported against Advantage (Stress Urinary Incontinence).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2021 General $9,658 67

Breakdown

Who paid General payments · program year 2021
  1. Boston Scientific Corporation $9,658 67 payments
Top recipients General payments · program year 2021
  1. Thomas Giudice Urogynecology and Reconstructive Pelvic Surgery · West Columbia, SC $5,400 56% · 1 payment
  2. Brent Parnell Urogynecology and Reconstructive Pelvic Surgery · Birmingham, AL $2,206 23% · 2 payments
  3. Daniel Stone Urogynecology and Reconstructive Pelvic Surgery · Phoenix, AZ $153 2% · 1 payment
  4. David Glassman Obstetrics & Gynecology · Phoenix, AZ $153 2% · 1 payment
  5. Max Cadena Urogynecology and Reconstructive Pelvic Surgery · Houston, TX $122 1% · 1 payment

The top 5 of 61 recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Urogynecology and Reconstructive Pelvic Surgery Obstetrics & Gynecology $8,554 89% · 20 practitioners
  2. Obstetrics & Gynecology $484 5% · 8 practitioners
  3. Urology $175 2% · 8 practitioners
  4. Gynecology Obstetrics & Gynecology $93 <1% · 1 practitioner
  5. Physician Assistant $67 <1% · 4 practitioners

The top 5 of 17 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. South Carolina $5,400 56% · 1 recipient
  2. Alabama $2,250 23% · 3 recipients
  3. Arizona $605 6% · 24 recipients
  4. Texas $590 6% · 9 recipients
  5. California $214 2% · 7 recipients

The top 5 of 15 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

67 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record